MKGAF
Price
$142.41
Change
+$3.26 (+2.34%)
Updated
Dec 11 closing price
Capitalization
59.16B
Intraday BUY SELL Signals
Interact to see
Advertisement

MKGAF

Header iconMKGAF Comparison
Open Charts MKGAFBanner chart's image
Merck KGaA
Price$142.41
Change+$3.26 (+2.34%)
Volume$460
Capitalization59.16B
MKGAF Comparison Chart in %
MKGAF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Bausch Health Companies (NYSE:BHC), Avadel Pharmaceuticals plc (NASDAQ:AVDL), BioCryst Pharmaceuticals (NASDAQ:BCRX), Tilray Brands Inc. (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

Market Cap

The average market capitalization across the Pharmaceuticals: Generic Industry is 4.29B. The market cap for tickers in the group ranges from 2.12K to 63.66B. AGN holds the highest valuation in this group at 63.66B. The lowest valued company is CANQF at 2.12K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Generic Industry was 1%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 19%. TEVJF experienced the highest price growth at 55%, while RGTLF experienced the biggest fall at -51%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Generic Industry was -35%. For the same stocks of the Industry, the average monthly volume growth was -18% and the average quarterly volume growth was -5%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 62
Price Growth Rating: 58
SMR Rating: 80
Profit Risk Rating: 89
Seasonality Score: 23 (-100 ... +100)
Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (MKGAF: $142.41)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MKGAF’s FA Score shows that 1 FA rating(s) are green while.

  • MKGAF’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MKGAF’s TA Score shows that 5 TA indicator(s) are bullish.

  • MKGAF’s TA Score: 5 bullish, 4 bearish.

Price Growth

MKGAF (@Pharmaceuticals: Generic) experienced а +4.33% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.50%. For the same industry, the average monthly price growth was -1.01%, and the average quarterly price growth was +19.25%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.50% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MKGAF
Capitalization59.2B
EBITDA5.87B
Gain YTD-6.037
P/E Ratio17.90
Revenue21.2B
Total Cash1.57B
Total Debt9.4B
FUNDAMENTALS RATINGS
MKGAF: Fundamental Ratings
MKGAF
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
69
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
76
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MKGAF
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
67%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 2 days ago
58%
Declines
ODDS (%)
Bearish Trend 4 days ago
65%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
MKGAF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LASE2.980.11
+3.83%
Laser Photonics Corp
BOC13.570.17
+1.27%
Boston Omaha Corp
EHC106.850.45
+0.42%
Encompass Health Corp
LPBBU10.56N/A
N/A
Launch Two Acquisition Corp
TWST32.12-0.66
-2.01%
Twist Bioscience Corp

MKGAF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MKGAF has been loosely correlated with MKKGY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MKGAF jumps, then MKKGY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MKGAF
1D Price
Change %
MKGAF100%
+2.35%
MKKGY - MKGAF
49%
Loosely correlated
+2.91%
AQST - MKGAF
19%
Poorly correlated
+1.44%
INDV - MKGAF
17%
Poorly correlated
+0.96%
EVO - MKGAF
17%
Poorly correlated
+2.33%
EBS - MKGAF
16%
Poorly correlated
+1.38%
More